Investment analysts at StockNews.com started coverage on shares of SenesTech (NASDAQ:SNES – Get Free Report) in a report issued on Saturday. The brokerage set a “sell” rating on the stock.
Separately, HC Wainwright upped their price objective on shares of SenesTech from $3.50 to $10.00 and gave the stock a “buy” rating in a report on Thursday, December 12th.
View Our Latest Research Report on SNES
SenesTech Stock Performance
SenesTech Company Profile
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Featured Stories
- Five stocks we like better than SenesTech
- Stock Sentiment Analysis: How it Works
- Cold Front, Hot Stocks: Diesel Prices Propel Energy Leaders
- How to Effectively Use the MarketBeat Ratings Screener
- Sustainable and Successful: 3 Climate ETFs Beating the Market
- Stock Market Upgrades: What Are They?
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.
